Home  >  Research  >  Labs  >  Cancer Program  >  BRITElab

RESEARCH OVERVIEW

Bioimaging Research and Innovation for Translational Engineering Laboratory (BRITElab) focusses on the development and translation of novel imaging techniques to a range of clinical and biological applications.

A particular technique being developed in BRITElab is optical elastography: an imaging technique that provides a map of the mechanical properties of tissue. It involves three main steps: applying a mechanical load to a tissue; measuring the resulting deformation using optical imaging; and using algorithms to estimate a mechanical property from the measured deformation.

As the mechanical properties of tissue are invariably altered by disease, optical elastography has broad applications in areas such as vascular biology, tumour biology, physiology and cancer imaging.

The team is very actively developing optical elastography for tumour margin assessment in breast-conserving surgery. The goal of this project is to provide the surgeon with a tool allowing them to more effectively remove tumour during surgery. If successful, this could lead to a reduction in the amount of patients, currently 20-30%, that require additional surgery.

Dr Brendan Kennedy

Dr Brendan Kennedy

BRITElab (Theme Head - Biomed Engineering)

Read more

Technology to help surgeons remove all traces of breast cancer

LATEST NEWS

1000 walkers raise over $1.45m for women’s cancer research

Taking steps to reduce the devastating impact of cancer on women. Fast Facts On average 69,000 new cases of cancer are diagnosed in Australian women each year. One in two…

Read More
image shows ovarian cancer cells from various patients in various colours to show tumour elements

“Google map” of ovarian tumours reveals cancer cells control who gets into their neighbourhood

Perth researchers find some ovarian cancer cells appear to tell immune system to stay away. “Spatial transcriptomics reveals discrete tumour microenvironments and autocrine loops within ovarian cancer subclones” published in…

Read More

Predicting immunotherapy effectiveness in late-stage liver cancer

Blood test could hold key to identifying who will respond to immunotherapy after researchers discover biomarkers in liver cancer tissue. Liver cancer researchers at the Harry Perkins Institute of Medical…

Read More

I'M LOOKING FOR

RESEARCH PROJECTS

TEAM MEMBERS

PUBLICATIONS